Reviewing Human Pheromone Sciences (OTCMKTS:EROX) & Oddity Tech (NASDAQ:ODD)

Oddity Tech (NASDAQ:ODD) and Human Pheromone Sciences (OTCMKTS:EROX) are both computer and technology companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Analyst Recommendations

This is a breakdown of current recommendations for Oddity Tech and Human Pheromone Sciences, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oddity Tech	0	3	5	0	2.63
Human Pheromone Sciences	0	0	0	0	N/A

Oddity Tech currently has a consensus price target of $53.75, suggesting a potential upside of 37.50%. Given Oddity Tech’s higher possible upside, research analysts clearly believe Oddity Tech is more favorable than Human Pheromone Sciences.

Profitability

This table compares Oddity Tech and Human Pheromone Sciences’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Oddity Tech	12.97%	26.10%	17.35%
Human Pheromone Sciences	N/A	N/A	N/A

Insider and Institutional Ownership

35.9% of Oddity Tech shares are held by institutional investors. 20.7% of Human Pheromone Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Oddity Tech and Human Pheromone Sciences’ revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oddity Tech	$554.66 million	4.01	$58.53 million	$1.20	32.58
Human Pheromone Sciences	N/A	N/A	N/A	N/A	N/A

Oddity Tech has higher revenue and earnings than Human Pheromone Sciences.

Summary

Oddity Tech beats Human Pheromone Sciences on 7 of the 8 factors compared between the two stocks.

About Oddity Tech

Oddity Tech Ltd. operates as a consumer tech company that builds digital-first brands for the beauty and wellness industries in the United States and internationally. It serves consumers worldwide through its AI-driven online platform, which uses data science, machine learning, and computer vision capabilities to identify consumer needs, and develop solutions in the form of beauty and wellness products. The company sells beauty, hair, and skin products under the IL MAKIAGE and SpoiledChild brands. In addition, it operates ODDITY LABS, a biotechnology center, which develops various ingredients, including novel molecules, probiotics, and peptides for beauty and wellness products. Oddity Tech Ltd. was incorporated in 2013 and is headquartered in Tel Aviv, Israel.

About Human Pheromone Sciences

Human Pheromone Sciences, Inc. engages in the research, development, manufacture, and marketing of consumer products containing synthetic human pheromones and other mood enhancing compounds in the United States and internationally. It provides a line of fragrance and toiletry products for men and women under the Natural Attraction trademark. The company also licenses its initial compounds and related technology, as well as sells its patented compounds to licensed customers to include these compounds as components in their products. In addition, it offers private label manufacturing services to licensed customers. Human Pheromone Sciences, Inc. distributes its products through distributors, as well as through the Web site, naturalattraction.com. The company was formerly known as EROX Corporation and changed its name to Human Pheromone Sciences, Inc. in May 1998. Human Pheromone Sciences, Inc. was founded in 1989 and is headquartered in San Jose, California.